Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Heather Wakelee, MD
Stanford University, Palo Alto, CA, USA
Principal Investigator - Karen L Reckamp, MD
City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Principal Investigator - Suresh S. Ramalingam, MD
Emory University School of Medicine, Atlanta, GA, USA
Principal InvestigatorKOL profile → - Vali A. Papadimitrakopoulou, MD
MD Anderson Cancer Center, Houston, TX, USA
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cepcm - Hopital Timone
Marseille, France
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Start-Madrid-Ciocc
Madrid, Spain
- Start-Madrid-Fjd
Madrid, Spain
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Stanford University
Palo Alto, California, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2015
- Primary completion
- 31 Oct 2019
- Completion
- 31 Oct 2019
- Last update posted
- 29 Oct 2019
- Registered enrollment
- 28
- Registry id
- NCT02448251
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.